Top Markets
#1 Useless Coin Useless Coin +40.04%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.79%
#3 StonkBroker StonkBroker +36.44%
#4 0G 0G +35.41%
#5 SAFEcoin SAFEcoin +28.81%
#6 Arbitrum Arbitrum +19.69%
#7 Zora Zora +19.48%
#8 Dogs Dogs +18.55%
#9 Full Moon Full Moon +18.06%
#10 Notcoin Notcoin +18.00%
Coin of the day
Useless Coin Useless Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Rank in Stocks #13828
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Share Price
$4.36
Market Cap
$457.32M
Change (1 day)
0.69%
Change (1 year)
289.29%
Country
US
Trade Relmada Therapeutics, Inc. (RLMD)

Category

Healthcare
Stock price history for Relmada Therapeutics, Inc. (RLMD)
Highest end of day price: $4.68 on 2026-08-01

Lowest end of day price: $11.43 on 2014-06-01
Stock price history of Relmada Therapeutics, Inc. from 2014 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 10.22%
2025 860.47%
2024 -36.35%
2023 -17.50%
2022 -78.37%
2021 -41.31%
2020 -14.84%
2019 756.21%
2018 52.34%
2017 -6.63%
2016 -71.17%
2015 -80.90%
2014 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.87%
CH